Pregalin

Pregalin

pregabalin

Manufacturer:

Atlantic Lab

Distributor:

Atlantic Pharma

Marketer:

Atlantic Pharma
Concise Prescribing Info
Contents
Pregabalin
Indications/Uses
Neuropathic pain associated w/ diabetic peripheral neuropathy or w/ spinal cord injury & postherpetic neuralgia in adults. Generalized anxiety disorder in adults. Management of fibromyalgia in adults. Adjunct to partial seizures w/ or w/o secondary generalization in adults.
Dosage/Direction for Use
Doses may be given in 2 or 3 divided doses daily. When discontinuing, taper off gradually over at least 1 wk. Generalized anxiety disorder Initially 150 mg daily. May be increased in steps of 150 mg at wkly intervals to max of 600 mg daily. Neuropathic pain Initially 150 mg daily. May be increased to 300 mg daily after 3-7 days, then further increase to 600 mg daily after another 7 days. Diabetic neuropathy Max: 300 mg daily. Fibromyalgia Initially 150 mg daily. May be increased to 300 mg daily after 1 wk, then further increase to 450 mg daily if necessary. Epilepsy Initially 150 mg daily. May be increased to 300 mg daily after 1 wk, then further increase to 600 mg daily after another wk. Renal impairment w/ CrCl ≥60 mL/min 150 mg bid or tid, 300 mg bid or tid, 450 mg bid or tid, 600 mg bid or tid, 30-60 mL/min 75 mg bid or tid, 150 mg bid or tid, 225 mg bid or tid, 300 mg bid or tid, 15-30 mL/min 25-50 mg once daily or bid, 75 mg once daily or bid, 100-150 mg once daily or bid, 150 mg once daily or bid, <15 mL/min 25 mg once daily, 25-50 mg once daily, 50-75 mg once daily, 75 mg once daily. Post-hemodialysis supplementary dose 25 mg daily schedule: 25 mg or 50 mg as single dose; 25-50 mg daily schedule: 50 mg or 75 mg as single dose; 50-75 mg daily schedule: 75 mg or 100 mg as single dose; 75 mg daily schedule: 100 mg or 150 mg as single dose.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Discontinue treatment if life-threatening angioedema w/ resp compromise requiring emergency treatment; blisters, dyspnea, hives, rash, skin redness, & wheezing occur. Monitor patients for worsening of depression, suicidal thoughts or behavior, & any unusual changes in mood or behavior. May cause peripheral edema; dizziness & somnolence; wt gain. Blurred vision. Creatine kinase elevations, decreased platelet count, & mild PR interval prolongation. CHF patients w/ NYHA class III or IV cardiac status. Gradually w/draw therapy to minimize potential of increased seizure frequency in patients w/ seizure disorders. Discontinue gradually over a min of 1 wk if it is to be discontinued. May impair ability to drive or operate machines. Pregnancy. Not recommended in lactation. Childn <18 yr.
Adverse Reactions
Dizziness, somnolence. Hypersensitivity reactions; blurred vision, diplopia, increased appetite & wt gain, dry mouth, constipation (occasionally severe), vomiting, flatulence, euphoria, confusion, reduced libido, erectile dysfunction, irritability, vertigo, ataxia, tremor, dysarthria, paraesthesia, fatigue, oedema; disturbances of attention, memory, coordination, & gait; breast enlargement & gynecomastia. SJS.
Drug Interactions
Increased risk of developing angioedema w/ ACE inhibitors. Additive CNS depressant effects w/ CNS depressants including opiates & benzodiazepines. Additive effect on cognitive & gross motor functioning w/ lorazepam, ethanol & oxycodone. Increased risk of wt gain & peripheral edema w/ thiazolidinediones.
MIMS Class
Anticonvulsants / Anxiolytics / Drugs for Neuropathic Pain
ATC Classification
N02BF02 - pregabalin ; Belongs to the class of gabapentinoids. Used to relieve pain and other conditions.
Presentation/Packing
Form
Pregalin cap 150 mg
Packing/Price
4 × 14's
Form
Pregalin cap 75 mg
Packing/Price
4 × 14's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in